Skip to content
Opinion
Joe Nocera

How Allergan Continues to Make Drug Prices Insane

The company kept a promise to limit increases to the single digits. But it didn't stop abusing the patent system.
Patented.

Patented.

Photographer: Jean-Pierre Clatot/AFP/Getty Images

Jan. 1 isn't just a day for making New Year's resolutions and watching football. It's also become the day when the pharmaceutical industry unveils price increases, more or less en masse.

The good news, as a number of pharma and biotech analysts have noted, is that the increases for 2018 are smaller than in the past. According to Deutsche Bank's Gregg Gilbert, between 2013 and 2015 — that is, before Martin Shkreli jacked up the price of an AIDS drug from $13.50 to $750 a pill and made rising drug prices a national issue — the cost of drugs was rising more than 20 percent a year.